Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»A “Silent Killer” With No Treatment – Scientists Develop Game-Changing Drug
    Health

    A “Silent Killer” With No Treatment – Scientists Develop Game-Changing Drug

    By Monash UniversitySeptember 1, 2023No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Prescription Pills White Tablets
    A new oral drug, Muvalaplin, successfully lowers Lipoprotein(a) or Lp(a), a genetic form of cholesterol linked to heart attack and stroke, by up to 65%, marking a significant breakthrough as there is currently no approved treatment for high Lp(a) levels.

    A new drug presents the world’s first treatment for Lipoprotein(a), a predominantly genetic type of cholesterol that elevates the risk of cardiac arrest or stroke.

    Professor Stephen Nicholls, Director of the Victorian Heart Institute and Victorian Heart Hospital at Monash University, recently announced the development of a groundbreaking, world-first medication for Lipoprotein(a). This largely genetic form of cholesterol elevates the risk of heart attack and stroke.

    High levels of Lipoprotein(a), known as Lp(a) or spoken as ‘LP little a’, impact one in five people globally with no approved treatment currently on the market.

    Muvalaplin: The First Oral Lp(a)-Lowering Drug

    The trial demonstrated the success of Muvalaplin – the first oral drug ever developed to target Lp(a) – effectively lowering levels by up to 65%. It works by disrupting the ability for Lp(a) to form in the body.

    Professor Stephen Nicholls, renowned cardiologist and Director of Monash University’s Victorian Heart Institute and the Victorian Heart Hospital at Monash Health, led the landmark research and trial, recently presented at the European Society of Cardiology Congress in Amsterdam and published in JAMA.

    Lp(a) is similar to LDL cholesterol, sometimes called ‘bad cholesterol’, but is more sticky, increasing the risk of blockages and blood clots in arteries.

    Common LDL-lowering drugs such as statins don’t have the same lowering effect on Lp(a). Being largely genetic, Lp(a) is also difficult to control through diet, exercise, and other lifestyle changes.

    Although Lp(a) was discovered nearly 60 years ago there still aren’t any widely accessible treatments available to lower levels and reduce cardiovascular risk.

    Professor Nicholls said the global research industry has been working on a targeted solution to treat elevated Lp(a) for the past decade, but advancements so far have been in difficult to administer injection-based therapies that are not yet on the market.

    A Game-Changer for Cardiovascular Medicine

    “When it comes to treating high Lp(a), a known risk factor for cardiovascular disease, our clinicians currently have no effective tools in their kit,” Professor Nicholls said.

    “This drug is a game-changer in more ways than one. Not only do we have an option for lowering an elusive form of cholesterol, but being able to deliver it in an oral tablet means it will be more accessible for patients.”

    “Lp(a) is essentially a silent killer with no available treatment, this drug changes that.”

    Reference: “Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation” by Stephen J. Nicholls, Steven E. Nissen, Cynthia Fleming, Shweta Urva, Jeffrey Suico, Paul H. Berg, Helle Linnebjerg, Giacomo Ruotolo, P. Kellie Turner and Laura F. Michael, 28 August 2023, JAMA.
    DOI: 10.1001/jama.2023.16503

    The trial was undertaken in collaboration with Cleveland Clinic and Eli Lilly, the drug will now continue into larger phase clinical trials. It may also have potential to be used in the treatment of other vascular and valve disease

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Cholesterol Drugs Heart Attack Monash University Popular
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    The 12-Week Lifeline: A Fast-Acting Drug Combo That Could Stop Your Next Heart Attack

    New Gold Standard for Cholesterol Treatment Could Prevent 330,000 Deaths a Year

    Rethinking “Good” Cholesterol: Study Links High HDL-C Levels to Increased Dementia Risk

    New Drug Reverses Obesity Without Side Effects in Preliminary Tests

    Beware of Keto Diet: May Be Linked to Higher Risk of Heart Attacks and Cardiovascular Disease

    New Oral Drug Lowers Cholesterol by 70%

    31% Lower Risk of Death: A Safer and More Effective Drug for Treating the Most Serious Type of Heart Attacks

    A New, Non-Addictive Painkiller With Fewer Side Effects

    A Common Medication Improves Survival for Heart Failure Patients

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Scientists Discover Two Monster Black Holes at the Dawn of Time That Shouldn’t Exist

    Not All Physical Activity Protects Your Brain, Scientists Warn

    Rewriting History: New Research Reveals Ancient Iron Age King May Have Been a Woman

    A Strange Black Hole Gap Could Reveal Stars That Died Without Exploding

    A Deadly Blood Cancer May Begin More Than 50 Years Before Symptoms Appear

    Scientists Discover a Giant 66-Pound Rodent That Lived 34 Million Years Ago

    Scientists Unlock a New Way To Photograph Events That Vanish in Trillionths of a Second

    Why Do We Feel Colder As We Get Older? New Study Uncovers a Hidden Mechanism

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Scientists Discover That Producing Light More Slowly Could Improve Future Quantum Networks
    • A New Light-Powered Quantum Processor Could Overcome a Major Computing Barrier
    • Mysterious Radio Signals From 5,000 Light-Years Away Lead Scientists to a Surprising Discovery
    • New FDA-Approved Pill Lowers High Blood Pressure and May Slow Kidney Disease
    • Why Sleeping 9 Hours After 50 May Be a Warning Sign for Your Career
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.